Dramylin Syrup

Diphenhydramine + Ammonium chloride
"13.5mg, 131.5mg/5ml"
Kuwait Saudi Pharmaceutical Industries Co. (KSPICO)
Pack size 120ml Glass Bottle
Dispensing mode POM
Source KUWAIT
AgentINSPIRE DRUG STORE
Retail Price 6.50 AED

Indications

Dramylin Syrup is used for: For the symptomatic relief from dry, unproductive coughs due to upper respiratory tract infections.

Adult Dose

Based on oral liquid formulation containing Diphenhydramine 14 mg and Ammonium Chloride 130 mg per 5 mL. Oral Syrup ADULT & ELDERLY: 5-10 mL PO q4-6hr. Max. 40 mL/24 hr. Do not exceed the recommended dose

Child Dose

Based on oral liquid formulation containing Diphenhydramine 14 mg and Ammonium Chloride 130 mg per 5 mL. Oral Syrup CHILD (6 to 12 years): 5 mL PO 4 times daily. Not exceeding 30 mL/24 hr. CHILD (<6 years): Avoid use NOTE: Do not exceed the stated dose Not to be used for more than 5 days without the advice of a doctor. Parents or carers should seek medical attention if the child’s condition deteriorates during treatment

Renal Dose

Ammonium chloride is contraindicated in severe hepatic or renal impairment. Exercise caution in patient with mild to moderate renal or hepatic impairment

Administration

Contra Indications

Hypersensitivity to any of the ingredients. Children <6 years. Impaired hepatic or renal function because drug retention and subsequent ammonium toxicity or hepatic coma can occur in these patients. Avoid the use of antihistamines and codeine in the treatment of lower respiratory tract symptoms, including asthma Concurrent use of diphenhydramine and monoamine oxidase inhibitor (MAOI) therapy or within the last 14 days should be avoided, anticholinergic properties of diphenhydramine can be intensified by MAOIs. Known or suspected gastrointestinal obstruction, including paralytic ileus. Metabolic acidosis or respiratory acidosis due to possible worsening of these conditions

Precautions

Concomitant use of diphenhydramine with benzodiazepines, or other CNS depressants, including alcohol, may result in profound sedation. Avoid such combinations. Drugs having anticholinergic properties (e.g. Diphenhydramine) should be used with caution in patients with epilepsy, severe hypertension and cardiovascular disease, raised intra-ocular pressure including glaucoma; prostatic hypertrophy; bronchitis, bronchiectasis and bronchial asthma. Caution patient about driving or operating machinery while on this medication as it may cause drowsiness, dizziness, blurred vision and psychomotor impairment. Children and the elderly are more likely to experience neurological anticholinergic effects and paradoxical excitation (e.g. increased energy, restlessness, nervousness). Avoid use in elderly patients with confusion. Pregnancy & Lactation Pregnancy: The use of this medication is not recommended in pregnant women as safety in human pregnancy is not established. Lactation: There is no information on effects of this combination product on milk production; because of the potential for serious adverse reactions (including excess sedation) in a breastfed infant, breastfeeding is not recommended during treatment

Pregnancy-Lactation

Interactions

Other CNS depressants (including benzodiazepines, opioid analgesics, alcohol): Additive CNS depressant effects. Other anticholinergic drugs (e.g., atropine, TCAs): Concurrent use may cause additive anti-muscarinic effects. Diphenhydramine has anticholinergic property. Monoamine oxidase inhibitors (MAOIs): Anticholinergic properties of diphenhydramine can be intensified by MAOIs.

Adverse Effects

Side effects of Diphenhydramine + Ammonium chloride : Common: CNS effects such as drowsiness (paradoxical stimulation may occur, especially with high doses of diphenhydramine or in children and the elderly); dizziness, headache, impaired mental and physical performance. Gastrointestinal disturbances such as nausea, vomiting, diarrhoea Anticholinergic effects such as urinary retention, dry mouth, blurred vision, difficulty in micturition, thickened respiratory tract secretions. Rare: Hypotension, extrapyramidal effects, confusion, depression, sleep disturbances, tremor, convulsions, palpitation, arrhythmia, hypersensitivity reactions, blood disorders and liver dysfunction

Mechanism of Action

Note

Dramylin "13.5mg, 131.5mg/5ml" Syrup manufactured by Kuwait Saudi Pharmaceutical Industries Co. (KSPICO). Its generic name is Diphenhydramine + Ammonium chloride. Dramylin is availble in United Arab Emirates. Farmaco UAE drug index information on Dramylin Syrup is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Diphenhydramine + Ammonium chloride :